Back to News
Market Impact: 0.5

What Every CarMax Investor Should Know Before Buying

KMX
Corporate EarningsCorporate Guidance & OutlookManagement & GovernanceInterest Rates & YieldsConsumer Demand & RetailCompany FundamentalsAnalyst EstimatesAutomotive & EV
What Every CarMax Investor Should Know Before Buying

CarMax faces a make-or-break Dec. 18 earnings print after the stock plunged more than 50% YTD and 75% from its Nov 2021 high, leaving a $5.5bn market cap and interim leadership following the September CEO ouster. Persistent affordability pressures—average used-car prices near $26,000 and CarMax’s finance arm reporting an 11.2% average rate in Q2—have dented sales and wholesale activity, while analysts have pared the 12-month price target from $81 to $40 (14 holds, 2 buys). Valuation metrics are at multi-year lows (TTM P/E 11.2, P/S 0.2, P/B 0.9), making the company a deep-value turnaround if pricing and rates normalize, but management must stabilize operations and deliver clear guidance to re-attract investors.

Analysis

Market structure: KMX’s pain benefits independent used-car dealers, buy-here-pay-here lenders and lower-cost online competitors who can cherry-pick demand for older, higher-mileage inventory; OEM CPO programs may steal premium supply as trade-ins age. Pricing power is fractured — buyers are rate-sensitive (CarMax finance avg APR 11.2% in Q2) so margins compress until rates fall ~200bps; weaker used-vehicle wholesale prices tighten the floor for retail resale values. Cross-asset: rising delinquencies and falling collateral values increase auto-ABS spreads and depress ABS valuations; KMX equity weakness should push its credit spreads wider and raise CDS costs, with limited FX/commodity transmission beyond lower gasoline demand assumptions. Risk assessment: Immediate risk is an ugly print on Dec 18 that triggers a management credibility shock and >20% intraday drop; short-term (weeks/months) risks are a continued funding premium and inventory markdowns, long-term (quarters) risk is protracted margin pressure if Fed stays restrictive. Tail risks include a covenant breach at the finance arm, regulatory action on dealer practices, or a rapid collapse in wholesale prices (>15% yr/yr) forcing deeper impairments. Key hidden dependency: profitability is levered to ABS funding spreads and Manheim index moves; monitor Manheim and NADA weekly indices as primary catalysts. Trade implications: Tactical trade is asymmetric: establish a staged 2–3% long KMX equity position with 50% deployed pre-earnings hedged by 30–45 day 10% OTM puts, and the remainder added only if management issues a credible 12‑month recovery plan or if Manheim index stabilizes for two consecutive weeks. Relative play: long KMX vs short CVNA (size ratio 3:2) to capture stabilization in a lower-cost omnichannel player versus higher-leverage pure-play. If directional short, buy 3-month 15% OTM puts sized at 1–2% notional rather than naked shorting; reduce XLY exposure by 2–4% and reallocate to XLP or IG corporates until visibility improves. Contrarian angles: Consensus understates the valuation cushion (trailing P/E ~11, P/B ~0.9) that provides downside protection absent a funding shock — if Fed cuts by ~100–200bps in 6–12 months, a 40–60% re-rate is plausible assuming stabilization in finance spreads. The market may be over-discounting permanent market-share loss; however, aggressive cost cuts could backfire by eroding LTV on trade-ins and future growth. Historical analogue: cyclical retail troughs with operational resets (post-2010 retail restructurings) show recovery often lags macro improvement by 2–4 quarters, so time the size of conviction to that window.